ORGO | tickerfilter.com

Fundamental analysis

22%

Profitability 18%

Dept financing 13%

Liquidity 39%

Performance 25%

Company vs Stock growth

+ Add row to compare

Performance

5 Days

-1.71%

1 Month

-4.64%

3 Months

5.49%

6 Months

-17.48%

1 Year

0.70%

2 Year

-23.40%

Key data

Stock price

$2.88

P/E Ratio

-23.08

DAY RANGE

$2.85 - $2.95

EPS

-$0.12

52 WEEK RANGE

$1.96 - $4.71

52 WEEK CHANGE

-$0.01

MARKET CAP

381.816 M

YIELD

N/A

SHARES OUTSTANDING

132.575 M

DIVIDEND

N/A

EX-DIVIDEND DATE

N/A

NEXT EARNINGS DATE

11/07/2024

BETA

2.05

PUBLIC FLOAT

AVERAGE 10 VOLUME

$417,275

AVERAGE 30 VOLUME

$783,271

Company detail

CEO:
Region: US
Website: http://www.organogenesis.com
Employees: 1,073
IPO year: -

Issue type: Common Stock
Market: XNAS
Industry: Research and Development in Biotechnology (except Nanobiotechnology)
Sector: Professional, Scientific, and Technical Services

headquartered in canton, massachusetts, organogenesis inc. is a global leader in regenerative medicine, offering a portfolio of bioactive and acellular biomaterials products in advanced wound care and surgical biologics, including orthopedics and spine. organogenesis’ versatile portfolio is designed to treat a variety of patients with repair and regenerative needs.

ORGO - Organogenesis Holdings Inc - Ordinary Shares - Class A